Global X S&P Biotech ETF
CURE
Global X S&P Biotech ETF CURE Strategy
The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.
The investment objective & strategy is a summary of the investment's principal strategy as written in the prospectus. This information is pulled from the most recent product disclosure document.
ETFs News & Analysis
etfs
Young & Invested: Do you need both IVV and NDQ in your portfolio?
A closer look at the illusion of choice in a concentrated market.
etfs
Top-rated global real estate ETF
Delivering value through a distinctive, standout approach to global real estate investing.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,177.10 | 16.10 | -0.18% |
| CAC 40 | 8,272.44 | 58.60 | -0.70% |
| DAX 40 | 24,394.72 | 23.08 | -0.09% |
| Dow JONES (US) | 49,662.66 | 220.10 | 0.45% |
| FTSE 100 | 10,530.67 | 78.41 | -0.74% |
| HKSE | 26,487.48 | 126.41 | 0.48% |
| NASDAQ | 24,498.86 | 94.47 | 0.39% |
| Nikkei 225 | 59,349.17 | 524.28 | 0.89% |
| NZX 50 Index | 12,932.33 | 16.88 | 0.13% |
| S&P 500 | 7,126.28 | 17.14 | 0.24% |
| S&P/ASX 200 | 8,949.40 | 20.10 | -0.22% |
| SSE Composite Index | 4,085.08 | 2.95 | 0.07% |